Service Utilization for Lifetime Mental Disorders in U.S. Adolescents: Results of the National Comorbidity Survey–Adolescent Supplement (NCS-A) - 10/08/11
, Jian-ping He, M.Sc. a, Marcy Burstein, Ph.D. a, Joel Swendsen, Ph.D. b, Shelli Avenevoli, Ph.D. c, Brady Case, M.D. d, Katholiki Georgiades, Ph.D. e, Leanne Heaton, Ph.D. a, Sonja Swanson, Sc.M. a, Mark Olfson, M.D., M.P.H. f
Correspondence to Kathleen Ries Merikangas, Ph.D., National Institute of Mental Health, Genetic Epidemiology Research Branch, Building 35, Room 1A201, 35 Convent Drive, MSC #3720, Bethesda, MD 20892Résumé |
Objective |
Mental health policy for youth has been constrained by a paucity of nationally representative data concerning patterns and correlates of mental health service utilization in this segment of the population. The objectives of this investigation were to examine the rates and sociodemographic correlates of lifetime mental health service use by severity, type, and number of DSM-IV disorders in the National Comorbidity Survey–Adolescent Supplement.
Method |
Face-to-face survey of mental disorders from 2002 to 2004 using a modified version of the fully structured World Health Organization Composite International Diagnostic Interview in a nationally representative sample of 6,483 adolescents 13 to 18 years old for whom information on service use was available from an adolescent and a parent report. Total and sector-specific mental health service use was also assessed.
Results |
Approximately one third of adolescents with mental disorders received services for their illness (36.2%). Although disorder severity was significantly associated with an increased likelihood of receiving treatment, half of adolescents with severely impairing mental disorders had never received mental health treatment for their symptoms. Service rates were highest in those with attention-deficit/hyperactivity disorder (59.8%) and behavior disorders (45.4%), but fewer than one in five affected adolescents received services for anxiety, eating, or substance use disorders. Comorbidity and severe impairment were strongly associated with service utilization, particularly in youth with behavior disorders. Hispanic and non-Hispanic Black adolescents were less likely than their White counterparts to receive services for mood and anxiety disorders, even when such disorders were associated with severe impairment.
Conclusions |
Despite advances in public awareness of mental disorders in youth, a substantial proportion of young people with severe mental disorders have never received specialty mental health care. Marked racial disparities in lifetime rates of mental health treatment highlight the urgent need to identify and combat barriers to the recognition and treatment of these conditions.
Le texte complet de cet article est disponible en PDF.Key Words : epidemiology, adolescents, mental disorders, treatment, services
Plan
| An interview with the author is available by podcast at www.jaacap.org. |
|
| This work was supported by the Intramural Research Program of the National Institute of Mental Health. The views and opinions expressed in this article are those of the authors and should not be construed to represent the views of any of the sponsoring organizations, agencies, or U.S. Government. |
|
| The National Comorbidity Survey–Adolescent Supplement (NCS-A) and the larger program of related National Comorbidity Surveys are supported by the National Institute of Mental Health (U01-MH60220) and the National Institute of Drug Abuse (R01 DA016558) with supplemental support from Substance Abuse and Mental Health Services Administration, the Robert Wood Johnson Foundation (044708), and the John W. Alden Trust. The NCS-A was carried out in conjunction with the World Health Organization World Mental Health Survey Initiative. |
|
| The authors dedicate this article to their friend and colleague, Srirangam S. Shreeram, M.D., a devoted and exemplary child psychiatrist, whose tragic death they still mourn. |
|
| Disclosure: Dr. Olfson has received research support to Columbia University from Eli Lilly and Co. and Bristol-Myers Squibb. Drs. Merikangas, Burstein, Swendsen, Avenevoli, Case, Georgiades, and Heaton, and Ms. He, and Ms. Swanson report no biomedical financial interests or potential conflicts of interest. |
Vol 50 - N° 1
P. 32-45 - janvier 2011 Retour au numéro
Article précédent
- Disparities in Treatment for Substance Use Disorders and Co-Occurring Disorders for Ethnic/Racial Minority Youth
- Margarita Alegria, Nicholas J. Carson, Marta Goncalves, Kristen Keefe
- Familiality of Tourette Syndrome, Obsessive-Compulsive Disorder, and Attention-Deficit/Hyperactivity Disorder: Heritability Analysis in a Large Sib-Pair Sample
- Carol A. Mathews, Marco A. Grados
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?